PubRank

S Thelin

Author PubWeight™ 26.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The incidence of chronic post-sternotomy pain after cardiac surgery--a prospective study. Acta Anaesthesiol Scand 2001 1.69
2 Eosinophil granule proteins in cardiopulmonary bypass with and without heparin coating. Ann Thorac Surg 1995 1.40
3 The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase. FEBS Lett 1997 1.36
4 Images in cardiovascular medicine. Papillary fibroelastoma as an unusual source of repeated pulmonary embolism. Circulation 1994 1.11
5 Atelectasis is a major cause of hypoxemia and shunt after cardiopulmonary bypass: an experimental study. Anesthesiology 1997 1.11
6 Complement activation during cardiopulmonary bypass: effects of immobilized heparin. Ann Thorac Surg 1994 1.06
7 Characterization of the molecular mechanism involved in the activation of hyaluronan synthetase by platelet-derived growth factor in human mesothelial cells. Biochem J 1992 1.06
8 Variable FHIT transcripts in non-neoplastic tissues. Genes Chromosomes Cancer 1997 0.99
9 The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14. Cancer Res 1996 0.96
10 High incidence of Chlamydia pneumoniae in sclerotic heart valves of patients undergoing aortic valve replacement. Scand J Infect Dis 1997 0.95
11 Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg 1997 0.93
12 Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery. Scand Cardiovasc J 2000 0.91
13 Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass: a clinical study. Ann Thorac Surg 1993 0.91
14 Quality of life in survivors of thoracic aortic surgery. Ann Thorac Surg 1999 0.89
15 Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study. J Thorac Cardiovasc Surg 1992 0.86
16 Energy-related metabolites during and after induced myocardial infarction with special emphasis on the reperfusion injury after extracorporeal circulation. Acta Physiol Scand 2001 0.85
17 Use of a vital capacity maneuver to prevent atelectasis after cardiopulmonary bypass: an experimental study. Anesthesiology 1998 0.84
18 Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study. Eur J Cardiothorac Surg 1997 0.82
19 Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. Artif Organs 1990 0.80
20 Effects of heparin-coating of cardiopulmonary bypass circuits on leukocytes during simulated extracorporeal circulation. Cardiovasc Surg 1997 0.79
21 A new method of intrathecal PO2, PCO2, and pH measurements for continuous monitoring of spinal cord ischemia during thoracic aortic clamping in pigs. Surgery 2000 0.78
22 Thrombin generation during cardiopulmonary bypass using heparin-coated or standard circuits. Scand J Thorac Cardiovasc Surg 1995 0.78
23 Decreased blood loss after cardiopulmonary bypass using heparin-coated circuit and 50% reduction of heparin dose. Scand J Thorac Cardiovasc Surg 1992 0.78
24 Cell adhesion and tissue factor upregulation in oxygenators used during coronary artery bypass grafting are modified by the Corline Heparin Surface. Scand Cardiovasc J 2002 0.77
25 Improved myocardial protection by creatine phosphate in cardioplegic solution. An in vivo study in the pig during normothermic ischemia. Thorac Cardiovasc Surg 1987 0.77
26 Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg 1994 0.76
27 Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery. Artif Organs 1996 0.76
28 Remodeling of the thoracic aorta after stent grafting of type B dissection: a Swedish multicenter study. J Cardiovasc Surg (Torino) 2006 0.76
29 No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits. Ann Thorac Surg 2000 0.75
30 Circulating cytokines and granulocyte-derived enzymes during complex heart surgery. A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits. Scand J Thorac Cardiovasc Surg 1995 0.75
31 Heparin-coated CPB-sets increase biocompatibility and reduce endothelial cell damage in pigs. J Cardiothorac Anesth 1989 0.75
32 Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs. Scand Cardiovasc J 1997 0.75
33 A long distal prosthetic bypass grafting from descending aorta to distal peroneal artery. Sometimes it works! Eur J Vasc Endovasc Surg 2000 0.75
34 Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits. Thorac Cardiovasc Surg 1997 0.75
35 Enhanced protection of rat hearts during ischemia by phosphoenolpyruvate and ATP in cardioplegia. Thorac Cardiovasc Surg 1986 0.75
36 Metabolic and functional effects of creatine phosphate in cardioplegic solution. Studies on rat hearts during and after normothermic ischemia. Scand J Thorac Cardiovasc Surg 1987 0.75
37 Heparin-coated cardiopulmonary bypass circuits and 25% reduction of heparin dose in coronary artery surgery--a clinical study. Ups J Med Sci 1992 0.75
38 [Heart surgery in Sweden is sufficiently developed. Risk of expensive overuse]. Lakartidningen 1996 0.75
39 Extra-anatomic bypass from the ascending aorta for treatment of critical lower limb ischaemia. Eur J Vasc Endovasc Surg 2000 0.75
40 Nucleoside transport inhibition in ischemic myocardium results in enhanced taurine efflux. Eur J Pharmacol 2001 0.75
41 Interrelated effects of nucleoside mono- and triphosphates and phosphoenolpyruvate on rat hearts subjected to cardioplegic arrest at normothermia. Scand J Thorac Cardiovasc Surg 1987 0.75
42 Influence of low proximal aortic pressure on spinal cord oxygenation in experimental thoracic aortic occlusion. J Cardiovasc Surg (Torino) 2001 0.75
43 [Open heart surgery in patients over 70 years of age]. Lakartidningen 1983 0.75
44 Biochemical and functional effects of creatine phosphate in cardioplegic solution during aortic valve surgery--a clinical study. Thorac Cardiovasc Surg 1992 0.75
45 Type IV thoraco-abdominal aortic aneurysm complicated by an aorto-enteric fistula due to previous infrarenal aortic graft. Eur J Vasc Endovasc Surg 1999 0.75
46 The protein catalysing the conversion of D-dopachrome to 5,6-dihydroxyindole is a phenylpyruvate tautomerase (EC 5.3.2.1) Melanoma Res 1997 0.75
47 Metabolic and functional effects of phosphoenolpyruvate and adenosine triphosphate on rat hearts subjected to global ischemia. Scand J Thorac Cardiovasc Surg 1985 0.75
48 Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs. Scand Cardiovasc J 1997 0.75
49 [Pericardial effusion after open heart surgery is a complication with uncharacteristic symptoms]. Lakartidningen 1988 0.75
50 Continuous monitoring of intrathecal pO2, pCO2 and pH during surgical replacement of type II thoracoabdominal aortic aneurysm. Eur J Vasc Endovasc Surg 1998 0.75
51 Laser Doppler flowmetry estimating myocardial perfusion after internal mammary artery grafting. Scand J Thorac Cardiovasc Surg 1988 0.75
52 Discrepant outcome between myocardial energy-related metabolites and infarct size limitation during retroperfusion of the coronary sinus. Scand J Clin Lab Invest 2001 0.75
53 [Extracranial carotid artery aneurysm]. Lakartidningen 1987 0.75